Latest News

Results from the phase 3 POD1UM-303/InterAACT-2 trial demonstrated improved PFS and OS in patients with locally recurrent or metastatic SCAC.
Adding Retifanlimab to Chemo Yields Clinical Benefit in Inoperable SCAC

June 13th 2025

Results from the phase 3 POD1UM-303/InterAACT-2 trial demonstrated improved PFS and OS in patients with locally recurrent or metastatic SCAC.

The FDA decision follows phase 2 CANFOUR trial data showing a 2-year survival rate of 35% in IL1RAP-high metastatic pancreatic ductal adenocarcinoma.
Nadunolimab Earns FDA Fast-Track Designation in Metastatic PDAC

June 13th 2025

In patients 39 years and younger, a statistically significant association between colorectal cancer diagnosis and endometriosis was not observed.
Adverse Sexual Health Outcomes Appear More Likely in Women With CRC

June 12th 2025

Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.
Preoperative Counseling Increases Shared Decision-Making in CRC Surgery

June 11th 2025

Phase 2 data may support nivolumab plus low-dose ipilimumab as a promising option in patients with microsatellite instability–high gastric cancer.
Frontline Nivolumab Combo Shows Enduring Activity in MSI-H Gastric Cancer

June 10th 2025

More News